Loading Nifty 50, Nifty Bank, and Sensex…
Marksans Pharma Limited
MARKSANS · Corporate filings
NSE
Marksans Pharma Limited
MARKSANS · NSE · Healthcare
₹320.00
4.39%
As of 12 Nov 2026
Marksans Pharma Limited (MARKSANS) is listed on NSE in the Healthcare sector. It last traded at ₹320.00, up 4.39% on the session. Its 52-week range is ₹155.00 to ₹350.95.
Research output is rule-based and informational only. It is not investment advice.
Analytics for MARKSANS are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Marksans Pharma Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Announcement
Announcement
Announcement
Announcement
Market activity
Short selling - 2 shares
Market activity
Short selling - 1 shares
Insider trading
Market activity
Short selling - 1 shares
Market activity
Short selling - 1 shares
Announcement
Market activity
Short selling - 1 shares
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Dividend
Dividend - Re 0.90 Per Share Dividend - Re 0.90 Per Share
Ex-date: 20 Aug 2026
Dividend
Dividend - Re 0.80 Per Share Dividend - Re 0.80 Per Share
Ex-date: 01 Aug 2025
Dividend
Dividend - Rs 0.60 Per Share Dividend - Rs 0.60 Per Share
Ex-date: 17 Sep 2024
Dividend
Dividend - Re 0.50 Per Share Dividend - Re 0.50 Per Share
Ex-date: 07 Jun 2023
Dividend
Annual General Meeting/Dividend - Rs 0.25 Per Share Annual General Meeting/Dividend - Rs 0.25 Per Share
Ex-date: 19 Aug 2022
Dividend
Annual General Meeting/Dividend - Rs 0.25 Per Share Annual General Meeting/Dividend - Rs 0.25 Per Share
Ex-date: 15 Sep 2021
Other
Extra-Ordinary General Meeting Extra-Ordinary General Meeting
Ex-date: 01 Jul 2021
Dividend
Annual General Meeting/Dividend - Rs 0.10 Per Share Annual General Meeting/Dividend - Rs 0.10 Per Share
Ex-date: 22 Sep 2020
Dividend
Annual General Meeting/Dividend - Rs 0.05 Per Share Annual General Meeting/Dividend - Rs 0.05 Per Share
Ex-date: 19 Sep 2019
Dividend
Annual General Meeting/Dividend Re 0.05 Per Share Annual General Meeting/Dividend Re 0.05 Per Share
Ex-date: 19 Sep 2018
Dividend
Annual General Meeting/Dividend - Re 0.05 Per Share Annual General Meeting/Dividend - Re 0.05 Per Share
Ex-date: 19 Sep 2017
Dividend
Annual General Meeting/Dividend - Re 0.12 Per Share Annual General Meeting/Dividend - Re 0.12 Per Share
Ex-date: 22 Sep 2016
Dividend
Annual General Meeting/ Dividend - Re 0.12/- Per Share Annual General Meeting/ Dividend - Re 0.12/- Per Share
Ex-date: 23 Sep 2015
Dividend
Annual General Meeting / Dividend - Re 0.10/- Per Share Annual General Meeting / Dividend - Re 0.10/- Per Share
Ex-date: 18 Sep 2014
Other
Annual General Meeting Annual General Meeting
Ex-date: 19 Sep 2013
Other
Annual General Meeting Annual General Meeting
Ex-date: 20 Sep 2012
Other
Annual General Meeting Annual General Meeting
Ex-date: 22 Sep 2011
Other
Annual General Meeting Annual General Meeting
Ex-date: 22 Sep 2010
Other
Annual General Meeting Annual General Meeting
Ex-date: 17 Sep 2009
Other
Annual General Meeting Annual General Meeting
Ex-date: 23 Sep 2008
Board Meetings
04 Nov 2026
Marksans Pharma Limited has submitted to the Exchange, unaudited financial results for the quarter and half year ended September 30, 2026.
12 Aug 2026
Marksans Pharma Limited has submitted to the Exchange, the unaudited financial results for the quarter ended Jun 30, 2026.
03 Jul 2026
Marksans Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 03, 2026.
26 May 2026
Marksans Pharma Limited has submitted to the Exchange, the Audited financial results for the period ended March 31, 2026.